Evidence map›Paper›PMID 41674597›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Scalable and comprehensive mosaic variant calling using DRAGEN.

Sairam Behera, Massimiliano Rossi, Yina Wang, Michal B Izydorczyk, Duke Tran, Clifton L Dalgard, Ester Kalef-Ezra, Kavya Kottapalli, Heer Mehta, Gavin Parnaby and 14 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Sairam BeheraHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-9047-0203
Massimiliano RossiIllumina, Inc., San Diego, CA, USA.ORCID 0000-0002-3012-1394
Yina WangIllumina, Inc., San Diego, CA, USA.ORCID 0009-0000-6217-5031
Michal B IzydorczykHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0003-3461-1224
Duke TranIllumina, Inc., San Diego, CA, USA.
Clifton L DalgardDepartment of Anatomy, Physiology and Genetics, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA.
Ester Kalef-EzraUCL Queen Square Institute of Neurology, University College London, UK.ORCID 0000-0002-1297-3315
Kavya KottapalliHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-8456-6313
Heer MehtaHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-5357-2112
Gavin ParnabyIllumina, Inc., San Diego, CA, USA.ORCID 0009-0006-7432-8246
Oona Shigeno Risse-AdamsDepartment of Systems and Computational Biomedicine, Weill Cornell Medicine, New York, NY 10021.ORCID 0000-0002-4350-663X
Sonja W ScholzNeurodegenerative Diseases Research Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.ORCID 0000-0002-6623-0429
Helen ShenHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.ORCID 0009-0003-4093-0480
Theodore M NelsonDepartment of Systems and Computational Biomedicine, Weill Cornell Medicine, New York, NY 10021.ORCID 0000-0002-8600-0444
Arun VisvanathIllumina, Inc., San Diego, CA, USA.ORCID 0009-0000-9089-9184
Xinchang ZhengHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0001-5739-861X
Harsha DoddapaneniHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.
Thomas GarciaDepartment of Pathology & Immunology, Baylor College of Medicine, TX, USA.ORCID 0000-0001-7761-2660
Christopher E MasonDepartment of Systems and Computational Biomedicine, Weill Cornell Medicine, New York, NY 10021.ORCID 0000-0002-1850-1642
Christos ProukakisUCL Queen Square Institute of Neurology, University College London, UK.ORCID 0000-0001-6423-6539
James HanIllumina, Inc., San Diego, CA, USA.ORCID 0009-0002-0333-7568
Rami MehioIllumina, Inc., San Diego, CA, USA.ORCID 0009-0003-6908-103X
Severine CatreuxIllumina, Inc., San Diego, CA, USA.ORCID 0009-0008-1813-1240
Fritz J SedlazeckHuman Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0001-6040-2691

Funding

Genetic characterization of atypical parkinsonismZIANS003154 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI SCHOLZ, SONJA · 2016 to 2025
$15.4M
Comprehensive Somatic Variant Characterization at the HGSCUM1DA058229 · NIDA · BAYLOR COLLEGE OF MEDICINE · PI Harsha Vardhan Doddapaneni, RICHARD A GIBBS · 2023 to 2026
$15.0M
Frequency of variants of unknown significance by ancestry groups in the All of Us Research Program cohortU01HG011758 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI RICHARD A GIBBS, JAMES R. LUPSKI · 2021 to 2026
$13.8M
Weill Cornell/Rockefeller/Sloan Kettering MST ProgramT32GM152349 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI KATHARINE C HSU · 2024 to 2026
$6.6M
Search for new genes involved in male infertility through novel approachesR01HD106056 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI Thomas Garcia · 2022 to 2026
$2.7M
Identification of somatic/ mosaic SV and transposon activity and their crosstalk to DNA epigenetic ModificationsUH3NS132105 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI Fritz J Sedlazeck, Tao Wu · 2025 to 2026
$994k
Intramural NIH HHS ZIA NS003154NHGRI NIH HHS U01 HG011758NICHD NIH HHS R01 HD106056NIDA NIH HHS UM1 DA058229NIGMS NIH HHS T32 GM152349NINDS NIH HHS UH3 NS132105
6 · The paper itself

Abstract

Detecting low variant allele fraction (VAF) mosaic variants without matching controls remains a major challenge in genomics, limited by technical noise, lack of benchmarks, and computational scalability. We present the DRAGEN mosaic caller, a hardware-accelerated approach identifying variants down to ~1-2% VAF with low false-positive rates and hour-scale runtimes for mosaic SNV/indel detection from bulk sequencing. To support evaluation, we introduce a genome-wide low-VAF benchmark for variants between 1-10% VAF. Application to blood, sperm, and brain tissues revealed patterns, including mosaic hotspots and mutational signatures. The first analysis of HG002 blood showed that many "mosaic" variants defined from HG002 cell lines are likely culture-derived and not in vivo mutations. Importantly, DRAGEN also enables personalized assembly pangenome references to improve alignment and mosaic variant detection in complex regions. Together, this development makes routine low-VAF discovery feasible, opening new opportunities to study mosaic mutations in healthy and disease individuals.

Identifiers

PMID41674597
PMCPMC12889792

What Socratic holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.